JenYang Chang - TTY Biopharm Chief Officer
| 4105 Stock | TWD 75.50 0.80 1.07% |
Insider
JenYang Chang is Chief Officer of TTY Biopharm Co
| Phone | 886 2 2652 5999 |
| Web | https://eng.tty.com.tw |
TTY Biopharm Management Efficiency
The company has return on total asset (ROA) of 0.0824 % which means that it generated a profit of $0.0824 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2093 %, meaning that it generated $0.2093 on every $100 dollars invested by stockholders. TTY Biopharm's management efficiency ratios could be used to measure how well TTY Biopharm manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Iris Su | Far EasTone Telecommunications | N/A | |
| Ivan Chen | Wistron Information Technology | N/A | |
| David Yen | Wistron Information Technology | N/A | |
| WeiYang Peng | Trade Van Information Services | N/A | |
| Allen Cheng | Cameo Communications | N/A | |
| Amy Wang | Cameo Communications | N/A | |
| HuiPing Yen | Trade Van Information Services | N/A | |
| Doris Hsieh | Cameo Communications | N/A | |
| Jamie Liu | Wistron Information Technology | N/A | |
| NienTe Fang | Trade Van Information Services | N/A | |
| Jian Liu | Wistron Information Technology | N/A | |
| JunXia Jiang | Trade Van Information Services | N/A | |
| Peter Hu | Far EasTone Telecommunications | N/A | |
| Chang Phoebe | Wistron Information Technology | N/A | |
| GuoFeng Kao | Trade Van Information Services | N/A | |
| Jake Lee | Mercuries Data Systems | N/A | |
| Wenchu Chen | Mercuries Data Systems | N/A | |
| Tian Chen | Cameo Communications | N/A | |
| Ching Hsiao | Wistron Information Technology | N/A | |
| Qing Chen | Cameo Communications | N/A | |
| HuiYi Lin | Trade Van Information Services | N/A | |
Management Performance
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0824 |
TTY Biopharm Leadership Team
Elected by the shareholders, the TTY Biopharm's board of directors comprises two types of representatives: TTY Biopharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of TTY. The board's role is to monitor TTY Biopharm's management team and ensure that shareholders' interests are well served. TTY Biopharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, TTY Biopharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| SiYuan Yang, VP | ||
| KuoChiang Chang, Corp CFO | ||
| ShuFen Huang, Chief Officer | ||
| WeiYing Yin, Director Department | ||
| JenYang Chang, Chief Officer | ||
| ShuWen Wang, Accounting Officer | ||
| Allen Chu, Head Unit | ||
| ChingLan Hou, G Mang | ||
| YungMin Chiang, Internal Officer |
TTY Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is TTY Biopharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0824 | |||
| Profit Margin | 0.24 % | |||
| Operating Margin | 0.26 % | |||
| Current Valuation | 20.05 B | |||
| Shares Outstanding | 248.65 M | |||
| Shares Owned By Insiders | 20.58 % | |||
| Shares Owned By Institutions | 17.40 % | |||
| Price To Earning | 13.04 X | |||
| Price To Book | 3.78 X |
Pair Trading with TTY Biopharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if TTY Biopharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in TTY Biopharm will appreciate offsetting losses from the drop in the long position's value.Moving together with TTY Stock
The ability to find closely correlated positions to TTY Biopharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace TTY Biopharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back TTY Biopharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling TTY Biopharm Co to buy it.
The correlation of TTY Biopharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as TTY Biopharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if TTY Biopharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for TTY Biopharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for TTY Stock Analysis
When running TTY Biopharm's price analysis, check to measure TTY Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TTY Biopharm is operating at the current time. Most of TTY Biopharm's value examination focuses on studying past and present price action to predict the probability of TTY Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TTY Biopharm's price. Additionally, you may evaluate how the addition of TTY Biopharm to your portfolios can decrease your overall portfolio volatility.